http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105326896-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97c915fa24a8ec723bd0c24e350e97b2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb41030958829f899cb456771f9838fc |
| publicationDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105326896-A |
| titleOfInvention | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type non-small cell lung cancer combined with hypercoagulability |
| abstract | The invention relates to a traditional Chinese medicine composition for treating a qi deficiency and blood stasis type non-small cell lung cancer combined with hypercoagulability, which belongs to the technical field of medicine. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight: 4 to 8 parts of rhizoma et radix polygoni-cuspidatl, 4 to 8 parts of myriopteron extensum, 4 to 8 parts of dysosma versipellis, 4 to 8 parts of aralia undulata, 4 to 8 parts of mango stones, 4 to 8 parts of red snow lotus and 4 to 8 parts of liquorice. All of the medicines are combined, so as to achieve the effects of invigorating the spleen, replenishing qi, promoting blood circulation, reducing phlegm and promoting qi circulation, the etiology and pathogenesis of the qi deficiency and blood stasis type non-small cell lung cancer combined with the hypercoagulability are closely followed, and research results find that the FBI, DD and FDP levels can be reduced by the traditional Chinese medicine composition and indicate that a good effect is achieved in the aspect of improving the blood hypercoagulability of a patient with the non-small cell lung cancer. |
| priorityDate | 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.